In a previous study we identified MUC1-expressing tumors as an immune-silent subgroup of ccRCC, characterized by low immune infiltration, low expression of PD-L1, high M2-like tumor-associated macrophages response, and metabolic reprogramming [10, 11]. This evidence concerns the gene MUC1 and neoplasm.